Catoggio76
All Australian
- Sep 21, 2017
- 661
- 840
- AFL Club
- Carlton
Geez, talk about a cone of silence! Speak up you lot.
https://smallcaps.com.au/afl-teams-paradigm-biopharma-pain-relieving-medication/
AFL teams queue up for Paradigm Biopharma’s pain relieving medication
By
George Tchetvertakov
-
April 4, 2018
Several doctors from Australian Football League (AFL) clubs are taking advantage of Paradigm Biopharma’s (ASX: PAR) existing drug for the treatment for knee, hip and groin pain which has not responded to current therapies.
The drug is made available under the Therapeutics Goods Administration’s (TGA) Special Access Scheme (SAS).
According to Paradigm’s CEO Paul Rennie, seven AFL clubs have taken advantage of the new treatment, currently being used by 40-50 former and current AFL players with reportedly outstanding results.
One of the clubs confirmed to be using the treatment is Carlton Football Club, with at least three more Melbourne-based teams also cited as being participants.
Given the associated public interest, especially from footy fans that idolise the players playing for their teams, the AFL clubs involved in the use of the medication have been coy to provide exact details regarding which players have been treated by Paradigm’s patented drug candidate Pentosan Polysulfate Sodium (PPS).
...
In its current phase 2 trial, patients are administered with two injections of PPS per week for six weeks for a total of 12 injections.
....
With several AFL clubs confirmed to be using PPS, and with such great success being reported by patients, it may only be a matter of time until Paradigm’s PPS drug is being used by other AFL clubs and other high-performance sports in Australia and overseas.
Paradigm shares were up 7% and trading around $0.30 per share in light trade.
https://smallcaps.com.au/afl-teams-paradigm-biopharma-pain-relieving-medication/
AFL teams queue up for Paradigm Biopharma’s pain relieving medication
By
George Tchetvertakov
-
April 4, 2018
Several doctors from Australian Football League (AFL) clubs are taking advantage of Paradigm Biopharma’s (ASX: PAR) existing drug for the treatment for knee, hip and groin pain which has not responded to current therapies.
The drug is made available under the Therapeutics Goods Administration’s (TGA) Special Access Scheme (SAS).
According to Paradigm’s CEO Paul Rennie, seven AFL clubs have taken advantage of the new treatment, currently being used by 40-50 former and current AFL players with reportedly outstanding results.
One of the clubs confirmed to be using the treatment is Carlton Football Club, with at least three more Melbourne-based teams also cited as being participants.
Given the associated public interest, especially from footy fans that idolise the players playing for their teams, the AFL clubs involved in the use of the medication have been coy to provide exact details regarding which players have been treated by Paradigm’s patented drug candidate Pentosan Polysulfate Sodium (PPS).
...
In its current phase 2 trial, patients are administered with two injections of PPS per week for six weeks for a total of 12 injections.
....
With several AFL clubs confirmed to be using PPS, and with such great success being reported by patients, it may only be a matter of time until Paradigm’s PPS drug is being used by other AFL clubs and other high-performance sports in Australia and overseas.
Paradigm shares were up 7% and trading around $0.30 per share in light trade.
Last edited: